RWA
IMGN

Ropes Wealth Advisors’s Immunogen Inc IMGN Stock Holding History

Ropes Wealth Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-270
Closed -$2K – 839
2020
Q4 		$2K Hold
270
– – ﹤0.01% 672
2020
Q3 		$1K Buy
+270
New +$1.09K ﹤0.01% 599
2018
Q1 		– Sell
-915
Closed -$6K – 768
2017
Q4 		$6K Hold
915
– – ﹤0.01% 600
2017
Q3 		$7K Buy
+915
New +$6.08K ﹤0.01% 552
2016
Q1 		– Sell
-6
Closed – – 527
2015
Q4 		$0 Sell
6
-45
-88% -$554 ﹤0.01% 537
2015
Q3 		$0 Buy
+51
New +$746 ﹤0.01% 427

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ropes Wealth Advisors's IMGN Position: Q1 2021 in Review

Ropes Wealth Advisors sold out of Immunogen Inc (IMGN) in Q1 2021, closing a stake of 270 shares — an estimated $2K sold.

Ropes Wealth Advisors first reported a position in IMGN in Q3 2015 and held it in 6 quarters. The position peaked at $7K in Q3 2017. 217 funds tracked by Wall St. Rank hold IMGN as of Q1 2021.

  • Ropes Wealth Advisors reported no remaining Immunogen Inc position as of Q1 2021 after selling out during the quarter.
  • Ropes Wealth Advisors sold 270 Immunogen Inc shares in Q1 2021, an estimated $2K.
  • Ropes Wealth Advisors first reported a position in Immunogen Inc in Q3 2015 and held it in 6 quarters.
  • Ropes Wealth Advisors's Immunogen Inc position peaked at $7K in Q3 2017.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2021.

Based on Ropes Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.